Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
According to NICE guidance, GLP-1 receptor agonists for type 2 diabetes (NG28) are recommended when other treatments have not achieved adequate glycaemic control
Diabetes Care 37:2430
TGA-approved Australia 2024
A study on whether and how the activation of GLP-1R affects proliferation and apoptosis of human pancreatic cancer cells has demonstrated that GLP-1RAs might activate cAMP in a GLP-1R-dependent manner, subsequently inhibiting the AKT and ERK1/2 signaling pathways, hence inhibiting the growth of transplanted tumors in vivo , as well as inducing apoptosis and inhibiting the proliferation of a human pancreatic cancer cell line in vitro ( 225)
US$ 24.08
US$ 22.33
US$ 29.47
US$ 22.57
US$ 24.55
:format(jpg)/f.elconfidencial.com%2Foriginal%2Ff27%2Fb3a%2F460%2Ff27b3a460e92bcdc8635b6aa1b0eff12.jpg)
US$ 27.84
US$ 22.08
US$ 20.72
US$ 24.07
